Evidence map›Paper›PMID 32808709›Full record

ArticleThe Milbank quarterly2020

Situating the Continuum of Overdose Risk in the Social Determinants of Health: A New Conceptual Framework.

Ju Nyeong Park, Saba Rouhani, Leo Beletsky, Louise Vincent, Brendan Saloner, Susan G Sherman

Abstract read
In one paragraph

Article in The Milbank quarterly, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 89 papers.

0numbers the graph read from it
0cells of the map it votes in
89citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

89 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Trial
  4. Article
  5. Article
  6. Medical Toxicology is the Overdose Specialty: Implications for the Dimensions and Continuum of Overdose Care.Journal of medical toxicology : official journal of the American College of Medical Toxicology · 2026
    Article
  7. Article
  8. Reasoning, Contrastive, and In-Context Strategies for Opioid Use Stage Detection on Social Media.Proceedings of the ... Workshop on Patient-Oriented Language Processing · 2026
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

29 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Ju Nyeong ParkJohns Hopkins Bloomberg School of Public Health.
Saba RouhaniJohns Hopkins Bloomberg School of Public Health.
Leo BeletskySchool of Law and Bouvé College of Health Sciences, Northeastern University.
Louise VincentUrban Survivors Union.
Brendan SalonerJohns Hopkins Bloomberg School of Public Health.
Susan G ShermanJohns Hopkins Bloomberg School of Public Health.

Funding

Vaccine Response and Immunotherapeutics SWGP30AI094189 · NIAID · JOHNS HOPKINS UNIVERSITY · PI Richard E. Chaisson · 2012 to 2026
$67.0M
NIDA Epidemiology Training Program: Johns Hopkins UniversityT32DA007292 · NIDA · JOHNS HOPKINS UNIVERSITY · PI RENEE M. JOHNSON, Brion S Maher · 1993 to 2026
$17.7M
Police Training to Reduce Occupational Needlesticks and HIV among Substance UsersR01DA039073 · NIDA · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI BELETSKY, LEO, STRATHDEE, STEFFANIE A. · 2015 to 2019
$3.2M
Improving Access and Quality of care for Medicaid-Eligible Adults with Opioid Use DisorderK01DA042139 · NIDA · JOHNS HOPKINS UNIVERSITY · PI SALONER, BRENDAN K · 2017 to 2021
$917k
NIAID NIH HHS P30 AI094189NIDA NIH HHS K01 DA042139NIDA NIH HHS R01 DA039073NIDA NIH HHS T32 DA007292
6 · The paper itself

Abstract

Policy Points This article reconceptualizes our understanding of the opioid epidemic and proposes six strategies that address the epidemic's social roots. In order to successfully reduce drug-related mortality over the long term, policymakers and public health leaders should develop partnerships with people who use drugs, incorporate harm reduction interventions, and reverse decades of drug criminalization policies. CONTEXT: Drug overdose is the leading cause of injury-related death in the United States. Synthetic opioids, predominantly illicit fentanyl and its analogs, surpassed prescription opioids and heroin in associated mortality rates in 2016. Unfortunately, interventions fail to fully address the current wave of the opioid epidemic and often omit the voices of people with lived experiences regarding drug use. Every overdose death is a culmination of a long series of policy failures and lost opportunities for harm reduction.

methodsIn this article, we conducted a scoping review of the opioid literature to propose a novel framework designed to foreground social determinants more directly into our understanding of this national emergency. The "continuum of overdose risk" framework is our synthesis of the global evidence base and is grounded in contemporary theories, models, and policies that have been successfully applied both domestically and internationally.

findingsDe-escalating overdose risk in the long term will require scaling up innovative and comprehensive solutions that have been designed through partnerships with people who use drugs and are rooted in harm reduction.

conclusionsWithout recognizing the full drug-use continuum and the role of social determinants, the current responses to drug overdose will continue to aggravate the problem they are trying to solve.

Indexed as

Social Determinants of HealthAnalgesics, OpioidDrug OverdoseHarm ReductionHumansModels, TheoreticalOpioid EpidemicOpioid-Related DisordersRisk FactorsUnited StatesAnalgesics, Opioidaddictive behaviordrug useopioidssubstance use

Identifiers

PMID32808709
PMCPMC7482387

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.